-ADVERTISEMENT-

Tag: biotechnology

TEVA – one of the world’s leading ten manufacturers of pharmaceuticals and owner of RATIOPHARM since 2010, as well as global market leader for generics – is investing approximately €500 million for the large-scale production of state-of-the-art biotechnological active ingredients in Southern Germany. The new production line will...